FOXO TECHNOLOGIES INC. Net Income
FOXO TECHNOLOGIES INC. (FOXO) reported Net Income of $8.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for the quarter ending 2026-06-30 was $8.14M.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$1.45M.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$9.42M.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$1.88M.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for fiscal 2025 was -$12.43M.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for fiscal 2024 was -$12.41M.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for fiscal 2023 was -$26.45M.
- FOXO TECHNOLOGIES INC. net income (loss) attributable to parent for fiscal 2022 was -$95.25M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 8 month | Net Income (Loss) Attributable to Parent 8 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.14M 10-Q · filed 2026-08-14 | $6.69M 10-Q · filed 2026-08-14 | -$2.73M derived: sum of 3 quarters · filed 2026-08-14 | -$4.60M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2026-03-31 | -$1.45M 10-Q · filed 2026-05-15 | -$10.87M derived: sum of 2 quarters · filed 2026-05-15 | -$12.74M derived: sum of 3 quarters · filed 2026-05-15 | -$13.27M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-12-31 | -$9.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$11.29M derived: sum of 2 quarters · filed 2026-04-15 | -$11.81M derived: sum of 3 quarters · filed 2026-08-14 | -$12.43M 10-K · filed 2026-04-15 | ||||||
| 2025-09-30 | -$1.88M 10-Q · filed 2025-11-10 | -$2.40M derived: sum of 2 quarters · filed 2026-08-14 | -$3.01M 10-Q · filed 2025-11-10 | -$9.81M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-06-30 | -$522.02K 10-Q · filed 2026-08-14 | -$1.14M 10-Q · filed 2026-08-14 | -$7.93M derived: sum of 3 quarters · filed 2026-08-14 | -$9.88M derived: sum of 4 quarters · filed 2026-08-14 | ||||||
| 2025-03-31 | -$616.46K 10-Q · filed 2026-05-15 | -$7.41M derived: sum of 2 quarters · filed 2026-05-15 | -$9.36M derived: sum of 3 quarters · filed 2026-05-15 | -$11.52M derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$8.74M derived: sum of 2 quarters · filed 2026-04-15 | -$10.90M derived: sum of 3 quarters · filed 2026-04-15 | -$12.41M 10-K · filed 2026-04-15 | ||||||
| 2024-09-30 | -$1.95M 10-Q · filed 2025-11-10 | -$1.95M 10-Q · filed 2024-11-19 | -$4.11M derived: sum of 2 quarters · filed 2025-11-10 | -$5.61M 10-Q · filed 2025-11-10 | -$5.61M 10-Q · filed 2024-11-19 | -$9.47M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$2.16M 10-Q · filed 2025-08-19 | -$2.16M 10-Q · filed 2024-08-19 | -$3.67M 10-Q · filed 2025-08-19 | -$3.67M 10-Q · filed 2024-08-19 | -$7.53M derived: sum of 3 quarters · filed 2025-08-19 | -$11.19M derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$1.50M 10-Q/A · filed 2025-08-19 | -$1.50M 10-Q · filed 2024-06-28 | -$5.36M derived: sum of 2 quarters · filed 2025-08-19 | -$9.02M derived: sum of 3 quarters · filed 2025-08-19 | -$20.32M derived: sum of 4 quarters · filed 2025-08-19 | |||||
| 2023-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$7.52M derived: sum of 2 quarters · filed 2025-04-15 | -$18.81M derived: sum of 3 quarters · filed 2025-04-15 | -$26.45M 10-K · filed 2025-04-15 | -$26.45M 10-K · filed 2024-06-06 | |||||
| 2023-09-30 | -$3.66M 10-Q · filed 2024-11-19 | -$14.95M derived: sum of 2 quarters · filed 2024-11-19 | -$22.59M 10-Q · filed 2024-11-19 | -$40.91M derived: sum of 4 quarters · filed 2024-11-19 | ||||||
| 2023-06-30 | -$11.29M 10-Q · filed 2024-08-19 | -$18.93M 10-Q · filed 2024-08-19 | -$37.26M derived: sum of 3 quarters · filed 2024-08-19 | -$78.28M derived: sum of 4 quarters · filed 2024-08-19 | ||||||
| 2023-03-31 | -$7.64M 10-Q · filed 2024-06-28 | -$25.96M derived: sum of 2 quarters · filed 2024-06-28 | -$66.99M derived: sum of 3 quarters · filed 2024-06-28 | -$90.53M derived: sum of 4 quarters · filed 2024-06-28 | ||||||
| 2022-12-31 | -$18.32M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | -$59.35M derived: sum of 2 quarters · filed 2024-06-06 | -$82.89M derived: sum of 3 quarters · filed 2024-06-06 | -$95.25M 10-K · filed 2024-06-06 | ||||||
| 2022-09-30 | -$41.03M 10-Q/A · filed 2024-06-04 | -$64.56M derived: sum of 2 quarters · filed 2024-06-04 | -$76.93M 10-Q/A · filed 2024-06-04 | -$77.81M derived: sum of 4 quarters · filed 2024-06-04 | ||||||
| 2022-06-30 | -$23.54M 10-Q · filed 2023-08-10 | -$132.25K 10-Q · filed 2022-08-12 | -$35.91M 10-Q · filed 2023-08-10 | -$509.23K 10-Q · filed 2022-08-12 | -$36.78M derived: sum of 3 quarters · filed 2023-08-10 | -$64.02M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$12.37M 10-Q · filed 2023-05-11 | -$13.24M derived: sum of 2 quarters · filed 2023-05-11 | -$40.48M derived: sum of 3 quarters · filed 2023-05-11 | -$42.34M derived: sum of 4 quarters · filed 2023-05-11 | ||||||
| 2021-12-31 | -$874.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$28.11M derived: sum of 2 quarters · filed 2023-03-31 | -$29.97M derived: sum of 3 quarters · filed 2023-03-31 | -$38.49M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | -$27.24M 10-Q · filed 2022-11-21 | -$29.10M derived: sum of 2 quarters · filed 2022-11-21 | -$37.61M 10-Q · filed 2022-11-21 | $3.51M 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | -$1.86M 10-Q · filed 2022-08-12 | $3.14M 10-Q · filed 2022-08-12 | ||||||||
| 2021-03-31 | $5.00M 10-Q · filed 2021-08-16 | |||||||||
| 2020-12-31 | -$1.78M 10-K/A · filed 2021-05-17 | -$37.71K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |